IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Enavate Sciences GP, LLC

Q3 2025 Holdings

Filed 2025-11-14 | 7 holdings | $327.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Zenas Biopharma Inc(ZBIO)COM98937L105$83.5M3,761,35925.5%
Sionna Therapeutics Inc(SION)COM829401108$72.9M2,478,03022.3%
Immunome Inc(IMNM)COM45257U108$55.8M4,768,58317.0%
Upstream BIO Inc(UPB)COM91678A107$46.3M2,459,70314.1%
Bridgebio Oncology Therapeut(BBOT)COM NEW107924102$30.4M2,626,9469.3%
Compass Therapeutics Inc(CMPX)COM20454B104$27.3M7,788,1508.3%
Camp4 Therapeutics Corp(CAMP)COM13463J101$11.4M3,785,8023.5%